Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Paul F. Dellaripa et al.|The Lancet Respiratory Medicine|2022Cited by 211
A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDSLaura E. Fredenburgh, Augustine M.K. Choi, Mark A. Perrella et al.|JCI Insight|2018Cited by 112
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIván O. Rosas, Augustine M.K. Choi, Hilary J. Goldberg et al.|CHEST Journal|2017Cited by 97